Novameds No-step Strep A Test REF: R-6009 is a unique, instant individual immunochromatographic in-vitro diagnostic assay for the direct detection of beta-hemolytic Group A Streptococcus antigen in throat swab specimens to aid in the diagnosis of streptococcal pharyngitis.
Novameds No-step Strep A Test device is based on the traditional platform of streptococcal antigen extraction and lateral flow assay, but the reagents and extraction procedure are built-in into a plastic casing and the process runs automatically upon the pressing of the button by the user.
Novameds No-step Strep A Test device utilizes Novameds proprietary technology which facilitates minimal user involvement in the testing process.
For ease, simplicity of procedure and rapidity of results, the No-step Strep A Test is recognized as a true Point-of-Care Test, allowing to correctly diagnose the streptococcal pharyngitis directly in doctors' offices, polyclinics and at home. This can prevent antibiotic overuse and mishandling of the regular test.
Product category: Other infectious immunology testing
Diagnostic products for “digital health” use - NovaCup
NovaCup is the first urine cup with an integrated full-panel urinalysis testing strip test provides with POC or home users quantifiable results on site without sending the urine sample to the laboratory.
NovaCup is a new concept of urinalysis allows to get the results of the urinalysis on site without any manual manipulation of the immersion of the urine strip in an opened urine container, followed by automatic reading the results using a digital reader (POC) or using the application installed in the smartphone (home).
Benefits: Reduce time to get the test results by the doctor, patient and laboratory. Reduce laboratory workloads. Reduce cost of testing. Increase global access to care. Improve the quality of care
Product category: Disposable articles for hospitals
Uni-Sep System for Lymphocytes isolation
Processing of peripheral blood mononuclear cells and lymphocytes for clinical or research applications aims to effectively isolate or deplete specific cell populations.
The success of the procedure, i.e. the recovery of viable lymphocytes with the lowest proportion of contaminating granulocytes and erythrocytes, depends to a large extent on the careful layering of the blood sample onto the separation medium and the maintenance of a sharp interface between the two solutions prior to centrifugation.
To this end, a new, innovative, ready-to-use UNI-SEP patented system was developed.
Due to the unique plastic insert, a blood sample can be poured directly into the UNI-SEP tube, with no special precautions required to prevent disruption of the separation medium layer.
The one-way feature of the insert allows passage of materials during the centrifugation step but prevents the flow of the separation medium during transportation.
Novamed, Ltd is a privately-owned Israeli life science company founded in December 1995. It operates in the In-Vitro Diagnostic (IVD) market from a 2,400 m2 facility in 19 Hartom St., Har Hotzvim, Jerusalem 9777518, Israel.
Novamed, Ltd maintains a staff of about 80 employees engaged in research, development, manufacturing and sales.
Novamed, Ltd is a leader in the development, manufacturing, and marketing of products used for diagnosing infectious diseases.